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pore by careful analysis of the electrostatic interactions
between the toxin and the residues constituting the
binding motif. Furthermore, the effort to crystallize the
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With this precedent, neurobiologists have dissected
the biology of ion channels by avidly exploiting the re-Chemical genetics, or the specific modulation of cellu-
lar systems by small molecules, has complemented markable specificity of a diverse array of small molecule
toxins and venoms, many of which are considered theclassical genetic analysis throughout the history of
neurobiology. We outline several of its contributions defining ligand for their respective targets (Bailey and
Wilce, 2001; Lewis, 2000).to the understanding of ion channel biology, heat and
cold signal transduction, sleep and diurnal rhythm reg- Probing Heat and Cold Sensation
with Small Moleculesulation, effects of immunophilin ligands, and cell sur-
face oligosaccharides with respect to neurobiology. The power of a small molecule-based approach to re-
ceptor biology has been elegantly illustrated in recent
years through the identification of the receptors respon-The contemporary neurological and psychiatric pharma-
sible for heat and cold sensation. It had been knowncopoeia employs a staggering array of small molecules
for some time that capsaicin, the cardinal irritant andof both natural and synthetic origin to modulate patho-
pungent component present in chili peppers (Figure 1),logical processes. It is therefore only fitting that few
was a highly selective compound unique among sensoryareas of science have benefited as much as neurobiol-
neuron agonists as it elicited a refractory period of de-ogy from the use of small molecules to explore cellular
sensitization following the initial stimulatory phase (Buckprocesses.
and Burks, 1986). In addition, Szallasi and BlumbergThe specific and discrete perturbation of the cellular
identified resiniferatoxin (RTX) as an especially potentmilieu by small molecules has been formalized as chemi-
but structurally divergent analog of capsaicin thatcal genetics (Crews and Splittgerber, 1999; Mitchison,
shares a homovanillyl moiety critical for biological activ-1994). The aims and strengths of this approach lie not
ity (Szallasi and Blumberg, 1990). The characterizationin the recapitulation of classical reverse genetics and
of structure-activity relationships and the discovery oftraditional genetic manipulation. Rather, chemical ge-
the capsaicin antagonist capsazepine (Walpole et al.,netics complements genetic analysis by affording ac-
1994) bolstered the notion of a vanilloid receptor, andcess to novel and previously hindered biological space.
its existence was finally confirmed by autoradiographicAmong the foibles of classical genetics are limitations
visualization of a tritiated resiniferatoxin probe in tissuesin the fine control of spatial and temporal dosimetry, as
of various species (Szallasi, 1995).well as its awkwardness in dissecting cases of functional
Later, capsaicin was used as a molecular probe in theredundancy or the tangled skeins of complex signaling
context of an expression cloning strategy to isolate thepathways.
first nociceptive receptor, vanilloid receptor 1 (VR1).Ion Channel Biology and Small Molecules
Characterization of VR1 revealed it to be a relative ofThis strategy hardly constitutes a novel or uncommon
the TRP ion channel and a nonselective cation channelapproach in neurobiological research. One familiar ex-
activated by capsaicin or elevated temperatures (Ca-ample is MacKinnon’s use of scorpion charybdotoxin
terina et al., 1997). Subsequently, other investigatorsas a specific and reversible inhibitor that enabled the
identified the capsaicin-like substance N-arachidonoyl-mechanistic elucidation of cellular ionic currents in po-
dopamine (NADA) as a putative endogenous ligandtassium channels.
(Huang et al., 2002). Intriguingly, a recent report identi-Using electrical methods, MacKinnon and colleagues
fied another TRP-related ion channel based on its abilitydemonstrated that scorpion toxin occluded potassium
to transduce menthol or cold stimulation. The discoverychannels without altering their gating properties. Since
this initial observation, scorpion toxin has been used of this new receptor family member, CMR1 (cold- and
liberally in the physical characterization of potassium menthol-sensitive receptor), suggests that TRP chan-
channels. The Drosophila gene Shaker, the first potas- nels play a general role in the signal transduction of
sium channel to be cloned, was extensively mutagen- thermal stimuli (McKemy et al., 2002).
ized to identify the residues essential for toxin binding. Sleep and Diurnal Rhythm Regulation
These data provided not only a primary sequence potas- by Small Molecules
sium channel signature, but also clues to probable sec- Chemical genetic approaches have proven equally facile
ondary and tertiary structural features. This in turn led with lipid-based compounds. For example, Cravatt and
to inferences regarding the physical size of the channel colleagues (1995) isolated the lipid oleamide, or cis-
9,10-octadecenoamide (cOA) (Figure 2), from the cere-
brospinal fluid of sleep-deprived cats, and demon-4 Correspondence: craig.crews@yale.edu
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Figure 2. Structures of Diurnal Rhythm Regulators (Oleamide, An-
andamide, 2-octyl -bromoacetoacetate, and N-bromoacetyltryp-
tamine)
possess additional properties, as it appears to interact
with mammalian voltage-gated sodium channels in a
manner reminiscent of many anaesthetics (Nicholson et
Figure 1. Structures of Capsaicin, Resiniferatoxin, Capsazepine, al., 2001).
and Menthol In a related system, small molecules have been em-
ployed in the analysis of the melatonin-pineal gland diur-
nal rhythm axis. The photoregulated enzyme serotoninstrated that exogenous synthetic oleamide induced
sleep in rats. N-acetyltransferase (arylalkylamine N-acetyltransferase
[AANAT]), transfers acetyl from acetyl-coenzyme A (ace-Believing this to represent a novel signaling pathway,
the investigators focused on elucidating an inactivating tyl-CoASH) to serotonin in the first and rate-limiting step
of N-acetylserotonin formation en route to the biosyn-mechanism, and noted an enzymatic activity that hy-
drolyzed oleamide and the related fatty acid endocan- thesis of melatonin (5-methoxy-N-acetyltryptamine).
AANAT also possesses a secondary alkyltransferase ac-nabinoid anandamide into oleic and arachadonic acids,
respectively. Mechanism-based isolation of this activity tivity, which is potently inhibited by the small molecule
N-bromoacetyltryptamine and its cognate N-haloacetyl-led to the purification and cloning of fatty acid amide
hydrolase (FAAH) (Cravatt et al., 1996). This line of in- tryptamines.
The acetyltransferase and alkyltransferase domainsquiry was supported by the observation that the human
cerebrospinal fluid isolate 2-octyl -bromoacetoace- of AANAT are functionally distinct, and the mechanism
of N-haloacetyltryptamine-mediated inactivation of AA-tate, which had been shown to lengthen REM-associ-
ated sleep in cats, also inhibited FAAH (Patricelli et al., NAT is rather unusual. In brief, N-haloacetyltryptamines
are prodrugs activated by transfer of CoASH at the alkyl-1998).
Although oleamide and anandamide provoke etholog- transferase active site to generate species that subse-
quently bind and inhibit an AANAT acetyltransferaseical responses consistent with the action of cannabin-
oids, only anandamide has been demonstrated to bind active site in either cis or trans.
A more subtle consequence is the potential amplifica-the cannabinoid receptor CB1. A recent study con-
ducted with FAAH-deficient mice established that both tion of the inhibitory signal, since the alkyltransferase
site remains unaffected by the inhibition of the physio-compounds are subject to catabolic regulation by FAAH,
but that only anandamide’s behavioral effects could be logically relevant acetyltransferase site. Hence, multiple
N-haloacetyltryptamine molecules can be converted toabolished by a deficiency of CB1 engineered by either
genetic means or pharmacological inactivation with the their inhibitory analogs even after their host enzyme’s
primary acetyltransferase activity has been neutralized.small molecule antagonist SR141716A (Lichtman et al.,
2002). Hence, it appears that oleamide and anandamide Cole and colleagues have termed this type of inhibition
“molecular fratricide,” and as the N-haloacetyltrypt-exert their effects virtually orthogonally in vivo. Explora-
tion of the chemical space surrounding oleamide and amines are the only cell-permeable AANAT inhibitors
described to date, these compounds hold much promiseanandamide has yielded a number of potent inhibitor
analogs, which would be of utility in further characteriza- for the elucidation of melatonin’s role in circadian rhythm
biology (Zheng and Cole, 2002).tion of these effects (Boger et al., 2000).
Various groups have shown interactions between Neurobiological Activities of Immunophilin
Ligandsoleamide and GABA(A) receptors, and ablation of the
3 subunit of GABA(A) receptors in a murine deficiency Small molecules such as cyclosporin A (CsA), FK506,
and rapamycin (Figure 3) are well characterized immu-system abrogates oleamide’s effects (Laposky et al.,
2001). There are even suggestions that oleamide may nosuppressive compounds that form ligand-receptor
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Figure 4. Structures of poly-2,8-sialic acid (PSA) Precursors (N-ace-
tylmannosamine [ManNAc], N-propanoylmannosamine [ManProp],
and N-butanoylmannosamine [ManBut])
Modulation of Cell Surface Chemistry
Using Small Molecules
Finally, we wish to address a model study of the specific
perturbation of a cellular system with small molecules
to generate novel insights into neuronal biology that
complements genetic analysis. Linear homopolymers
of the saccharide 2,8-sialic acid (poly-2,8-sialic acid
Figure 3. Structures of Immunophilin Ligands (FK506, GPI-1046,
[PSA]), are primarily concentrated on the cell surfaceand V-10,367)
upon neural cell adhesion molecules (NCAM) and play
an important role in neuronal development and synaptic
plasticity. Manipulation of PSA levels was previouslycomplexes with immunophilins, which in turn bind to
and inhibit secondary targets such as calcineurin or limited to either enzymatic digestion or genetic means.
The latter approach was inherently problematic, as mul-FRAP/RAFT1 (FKBP and rapamycin-associated protein/
rapamycin and FKBP12 target 1). These immunophilin tiple distinct enzymatic steps are responsible for the
synthesis of oligosaccharides such as endogenous PSA.ligands also exert a number of neurobiologically salient
activities, including neuroprotective and neurotrophic Bertozzi and colleagues (Mahal et al., 2001) recently
described the modulation of this oligosaccharide epi-effects for damaged neurons, modulation of neurotrans-
mitter release secondary to NOS inhibition, and nerve tope by using the small molecule N-butanoylmannosam-
ine (ManBut) (Figure 4) to inhibit PSA generation in aregeneration.
In an effort to dissect the effects of calcineurin inhibi- specific and reversible manner. ManBut is permitted
in lieu of the natural substrate N-acetylmannosaminetion from these neurobiological effects, rational drug
design of a nonimmunosuppressive ligand, which bound (ManNAc) in the cellular biosynthetic pathway leading
to cytidine 5-monophosphate-sialic acid (CMP-sialicthe immunophilin FKBP12, but not calcineurin, yielded
3-(3-pyridyl)-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxo- acid), the quantum of PSA fabrication, and is metaboli-
cally transformed into an unnatural chain-terminatingpentyl)-2-pyrrolidinecarboxylate (GPI-1046).
GPI-1046 acts as a neurotrophin that stimulates neu- derivative when incorporated into 2,8-sialic acid oligo-
mers undergoing extension. The closely related com-rite outgrowth, and it has also been credited with spur-
ring axonal regeneration following serious CNS injury to pound N-propanoylmannosamine (ManProp) is also a
suitable substrate for incorporation into unnatural sialiceither the optic nerve or spinal cord. It also exhibits
neuroprotective effects of varying degrees against le- acid derivative, but does not interfere with the iterative
catenation that leads to PSA and its analogs, renderingsions induced by 3-acetylpyridine, hydrogen peroxide,
6-hydroxydopamine, 1-methyl-4-phenylpyridinium, and it an excellent matched control.
In this system, tunable inhibition and temporal potenti-parachloroamphetamine. There is some evidence for a
protective elevation of antioxidative glutathione levels, ation of PSA expression is but a matter of adulterating
endogenous sialic precursor pools with ManBut in aalthough strong evidence for any direct target is lacking.
Interestingly, insult by 1-methyl-4-phenylpyridinium to dose-dependent fashion. ManBut treatment at ex-
tremely low doses would alter the nature of populationboth wild-type neuronal cells treated with GPI-1046 and
their FKBP12-deficient counterparts treated with FK506 of PSA to include both full-length as well as truncated
PSA molecules. Alternatively, increasing amounts ofresult in similar neuroprotective profiles, which further
supports a distinction between the immunosuppressive ManBut would attenuate both the population and mean
length of PSA molecules by prematurely terminatingand neuroprotective effects of immunophilin ligands.
Another nonimmunosuppressive immunophilin ligand PSA oligomers on average at increasingly earlier stages.
This chemical genetic approach will enable finer resolu-analog, V-10,367, also spurs neurite outgrowth in dopa-
minergic neuronal cell culture in addition to the accelera- tion of PSA epitope function in neuronal processes
through tractable methods (Mahal et al., 2001).tion of nerve regeneration in a rat model and neuropro-
tection in a murine traumatic brain injury (TBI) model. Conclusion
We have attempted to illustrate how chemical geneticOne group used the novel compound Lie120, a highly
specific calcineurin inhibitor, to distinguish the neuro- analysis of various neurobiological processes offers ad-
ditional analytical power in juxtaposition to traditionalprotective effects of FK506 and V-10,367 from calcineurin
inhibition. Their results suggested that calcineurin inhibi- forward and reverse genetic analysis. The chemical ge-
netic approach is limited theoretically only by the leveltion was strictly orthogonal to the neuroprotective ef-
fects of both FK506 and V-10,367 in cell culture (Snyder of specificity and bioavailability of the small molecules
marshaled in its employ. That said, precise target identi-et al., 1998a, 1998b).
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An endogenous sleep-inducing compound is a novel competitivethe elucidation of chemical genetic pathways.
inhibitor of fatty acid amide hydrolase. Bioorg. Med. Chem. Lett. 8,As evidenced by the continuous struggle to recapitu-
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late the synthesis of natural products, the exploitation
Snyder, S.H., Lai, M.M., and Burnett, P.E. (1998a). Immunophilins
of chemical space tendered by small molecule-based in the nervous system. Neuron 21, 283–294.
scaffolds is not yet a mature science. The promise of Snyder, S.H., Sabatini, D.M., Lai, M.M., Steiner, J.P., Hamilton, G.S.,
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